valproic acid has been researched along with Agnogenic Myeloid Metaplasia in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, Y | 1 |
| Suzuki, T | 1 |
| Takimoto, M | 1 |
| Irei, M | 1 |
| Yoshioka, S | 1 |
| Shibuya, Y | 1 |
| Kato, M | 1 |
| Koike, M | 1 |
| Takahashi, M | 1 |
1 other study available for valproic acid and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Treatment with valproic acid for myelofibrosis with myeloid metaplasia.
Topics: Aged; Anticonvulsants; Blood Cell Count; Epilepsy; Female; Hemorrhage; Humans; Primary Myelofibrosis | 2005 |